Malignant neoplasm of breast
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Liver carcinoma
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
Up-regulation of miR-143 expression transcribed by NF-kappaB in HBV-HCC promotes cancer cell invasion/migration and tumor metastasis by repression of FNDC3B expression.
|
19472311 |
2009 |
Malignant Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
Up-regulation of miR-143 expression transcribed by NF-kappaB in HBV-HCC promotes cancer cell invasion/migration and tumor metastasis by repression of FNDC3B expression.
|
19472311 |
2009 |
Neoplasm Metastasis
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
Up-regulation of miR-143 expression transcribed by NF-kappaB in HBV-HCC promotes cancer cell invasion/migration and tumor metastasis by repression of FNDC3B expression.
|
19472311 |
2009 |
Primary malignant neoplasm
|
0.050 |
AlteredExpression
|
group |
BEFREE |
Up-regulation of miR-143 expression transcribed by NF-kappaB in HBV-HCC promotes cancer cell invasion/migration and tumor metastasis by repression of FNDC3B expression.
|
19472311 |
2009 |
Secondary Neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Up-regulation of miR-143 expression transcribed by NF-kappaB in HBV-HCC promotes cancer cell invasion/migration and tumor metastasis by repression of FNDC3B expression.
|
19472311 |
2009 |
Liver carcinoma
|
0.070 |
Biomarker
|
disease |
BEFREE |
We selected two novel genes, fibronectin type III domain containing 3B (FNDC3B) at the 3q26.3 overlapped amplicon and solute carrier family 29 member 2 (SLC29A2) at the 11q13.2 overlapped amplicon, to investigate their aberrations in HCC tumorigenesis.
|
20799341 |
2010 |
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
We selected two novel genes, fibronectin type III domain containing 3B (FNDC3B) at the 3q26.3 overlapped amplicon and solute carrier family 29 member 2 (SLC29A2) at the 11q13.2 overlapped amplicon, to investigate their aberrations in HCC tumorigenesis.
|
20799341 |
2010 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Hundreds of variants clustered in genomic loci and biological pathways affect human height.
|
20881960 |
2010 |
Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Hundreds of variants clustered in genomic loci and biological pathways affect human height.
|
20881960 |
2010 |
Liver carcinoma
|
0.070 |
Biomarker
|
disease |
BEFREE |
FNDC3B was recently identified in an oncogenomic screen for amplified oncogenes in hepatocellular carcinoma.
|
22510613 |
2012 |
Malignant Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
We found that overexpression of FNDC3B induces the epithelial-to-mesenchymal transition (EMT) and activates several cancer pathways, including PI3-kinase/Akt, Rb1 and TGFβ signaling.
|
22510613 |
2012 |
Primary malignant neoplasm
|
0.050 |
AlteredExpression
|
group |
BEFREE |
We found that overexpression of FNDC3B induces the epithelial-to-mesenchymal transition (EMT) and activates several cancer pathways, including PI3-kinase/Akt, Rb1 and TGFβ signaling.
|
22510613 |
2012 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Activation of multiple cancer pathways and tumor maintenance function of the 3q amplified oncogene FNDC3B.
|
22510613 |
2012 |
Glaucoma, Primary Open Angle
|
0.350 |
Biomarker
|
disease |
BEFREE |
FNDC3B was also associated with primary open-angle glaucoma (P = 5.6 × 10(-4); tested in 3 cohorts with 2,979 cases and 7,399 controls).
|
23291589 |
2013 |
Glaucoma, Primary Open Angle
|
0.350 |
Biomarker
|
disease |
CTD_human |
FNDC3B was also associated with primary open-angle glaucoma (P = 5.6 × 10(-4); tested in 3 cohorts with 2,979 cases and 7,399 controls).
|
23291589 |
2013 |
Keratoconus
|
0.330 |
Biomarker
|
disease |
CTD_human |
We further showed that 2 CCT-associated loci, FOXO1 and FNDC3B, conferred relatively large risks for keratoconus in 2 cohorts with 874 cases and 6,085 controls (rs2721051 near FOXO1 had odds ratio (OR) = 1.62, 95% confidence interval (CI) = 1.4-1.88, P = 2.7 × 10(-10), and rs4894535 in FNDC3B had OR = 1.47, 95% CI = 1.29-1.68, P = 4.9 × 10(-9)).
|
23291589 |
2013 |
Keratoconus
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
We further showed that 2 CCT-associated loci, FOXO1 and FNDC3B, conferred relatively large risks for keratoconus in 2 cohorts with 874 cases and 6,085 controls (rs2721051 near FOXO1 had odds ratio (OR) = 1.62, 95% confidence interval (CI) = 1.4-1.88, P = 2.7 × 10(-10), and rs4894535 in FNDC3B had OR = 1.47, 95% CI = 1.29-1.68, P = 4.9 × 10(-9)).
|
23291589 |
2013 |
Glaucoma, Open-Angle
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus.
|
23291589 |
2013 |
Secondary Open Angle Glaucoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus.
|
23291589 |
2013 |
Corneal Topography
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus.
|
23291589 |
2013 |
Corneal Topography
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus.
|
23291589 |
2013 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.
|
23563607 |
2013 |
Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.
|
23563607 |
2013 |
heart rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders.
|
23583979 |
2013 |